Cairo – Mubasher: The extraordinary general meeting (EGM) of Ibnsina Pharma has approved an increase in the company's issued capital to EGP 280 million from EGP 240 million through the issuance of bonus shares.

The company's issued capital is distributed over 1.12 million shares at a nominal value of EGP 0.25 per share, according to a bourse filing on Sunday.

It is noteworthy to mention that in the first nine months of 2021, the company achieved consolidated net profits of EGP 241.94 million, up by 20.6% year-on-year (YoY) from EGP 200.61 million, including minority shareholders' rights.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2021 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.